Maven Securities’s Eli Lilly LLY Stock Holding History

Maven Securities’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,600	Closed	-$22.1M	–	490
2025 Q4	$22.1M	Buy	+20,600	New	+$19.7M	0.49%	46
2025 Q3	–	Sell	-21,700	Closed	-$16.9M	–	671
2025 Q2	$16.9M	Buy	21,700 +20,900	+2,613%	+$16.2M	0.4%	53
2025 Q1	$661K	Sell	800 -600	-43%	-$499K	0.02%	523
2024 Q4	$1.08M	Buy	+1,400	New	+$1.16M	0.03%	403
2024 Q3	–	Sell	-900	Closed	-$815K	–	995
2024 Q2	$815K	Buy	+900	New	+$720K	0.02%	570
2024 Q1	–	Sell	-9,100	Closed	-$5.3M	–	703
2023 Q4	$5.3M	Sell	9,100 -1,800	-17%	-$1.05M	0.11%	140
2023 Q3	$5.85M	Buy	10,900 +9,900	+990%	+$5.1M	0.07%	166
2023 Q2	$469K	Sell	1,000 -1,800	-64%	-$755K	0.01%	632
2023 Q1	$962K	Buy	+2,800	New	+$944K	0.02%	474
2022 Q4	–	Sell	-2,000	Closed	-$647K	–	994
2022 Q3	$647K	Sell	2,000 -2,300	-53%	-$729K	0.01%	693
2022 Q2	$1.39M	Hold	4,300	–	–	0.04%	289
2022 Q1	$1.23M	Buy	4,300 +3,000	+231%	+$772K	0.04%	287
2021 Q4	$359K	Buy	+1,300	New	+$330K	0.01%	637

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Maven Securities's LLY Position: Q2 2025 in Review

Maven Securities sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 4,370 shares — an estimated $3.4M sold.

Maven Securities first reported a position in LLY in Q1 2021 and held it in 13 quarters. The position peaked at $5.28M in Q1 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

Maven Securities reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
Maven Securities sold 4,370 Eli Lilly shares in Q2 2025, an estimated $3.4M.
Maven Securities first reported a position in Eli Lilly in Q1 2021 and held it in 13 quarters.
Maven Securities's Eli Lilly position peaked at $5.28M in Q1 2024.
3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Maven Securities's 13F filing for Q2 2025, filed 14 Aug 2025.